We are committed to finding a safe, effective, and patient-friendly therapy for food and pediatric allergy patients



Latest News

First Half of 2016 Condensed Consolidated Financial Statements

DBV Technologies Reports Interim Financial Results for the First Half of 2016


2016 first half results 

EAACI Congress 2016

The EAACI (European Academy Allergy and Clinical Immunology) Congress took place in Vienna from June 11th to 15th.

Epicutaneous Immunotherapy